Aug 30, 2026 Understanding the Power of GLP-1 Agonists
I cover 8 ESSENTIAL things you need to know BEFORE STARTING GLP1 medications like semaglutide or tirzepatide (Ozempic/Mounjaro) for weight loss without watching this first! I'm Dr G., an internal medicine physician in Hollywood Florida, and I specialize in lifestyle modification coaching and patient education. FREE TDEE Calculator👉https://www.fcmaesthetics.com/tdee 1:1 Consultation with Dr. G👉https://www.floridaconciergemed.com/ GLP-1 Meal Plan Delivery👉https://trifectanutrition.llbyf9.net/9g4vXe Use Code "DRGLP1" for 40% OFF Your First Order! Dr. Gerard Acloque Jr., MD Hollywood, FL #weightloss #glp1 #glp1forweightloss #semaglutide #tirzepatide Some of the links in this description are affiliate links, which means I may earn a small commission if you make a purchase through them, at no extra cost to you. References 1. Wilding, J. P., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., ... & Lau, D. C. (2021). Once-weekly semaglutide in adults with overweight or obesity. *New England Journal of Medicine*, 384(11), 989-1002. 2. Wadden, T. A., Bailey, T. S., Billings, L. K., Davies, M., Frias, J. P., Koroleva, A., ... & Lingvay, I. (2019). Effect of subcutaneous semaglutide on body weight in patients with obesity: The STEP 1 randomized clinical trial. *Obesity Reviews*, 20(12), 1997-2018. 3. Davies, M. J., Bergenstal, R., Bode, B., Kushner, R. F., Lewin, A., Skjøth, T. V., ... & Pedersen, S. D. (2015). Efficacy of liraglutide for weight loss among patients with type 2 diabetes: The SCALE diabetes randomized clinical trial. *JAMA*, 314(7), 687-699. 4. Holst, J. J. (2019). The physiology of glucagon-like peptide 1. *Physiological Reviews*, 97(2), 725-738. 5. Kushner, R. F., & Kahan, S. (2018). Introduction: The state of obesity in 2018. *Medical Clinics*, 102(1), 1-11. 6. Ryan, D. H., Lingvay, I., Colhoun, H. M., Deanfield, J., García-Pérez, L. E., Jodar, E., ... & Cosentino, F. (2021). Role of obesity in cardiovascular disease. *European Heart Journal Supplements*, 23(Supplement B), B45-B54. 7. Rubino, D., Abrahamsson, N., Davies, M., Hesse, D., Greenway, F. L., Jensen, C., ... & Van Gaal, L. (2021). Effect of continued weekly subcutaneous semaglutide on weight loss in adults with obesity: The STEP 1 trial extension. *The Lancet*, 397(10277), 2146-2155. This channel (Florida Concierge Medicine & Wellness/Dr. Gerard Acloque), its content, and the opinions expressed by Dr. G are intended for informational purposes only and do not constitute medical advice. The content provided on this channel, including videos, comments, and other materials, is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified and trusted health provider with any questions you may have regarding any medical condition. Never disregard professional medical advice or delay in seeking it because of something you have seen or read on this channel. Reliance on any information provided by this channel is solely at your own risk.
The mechanism is multifaceted. Instead of simply lowering blood sugar, GLP-1 agonists address the root causes of metabolic syndrome. They improve insulin sensitivity, slow down gastric emptying (which helps you feel fuller for longer), and enhance the body’s ability to utilize glucose efficiently. For individuals dealing with Type 2 diabetes or obesity, these drugs are often transformative, providing a comprehensive approach that goes far beyond simple glucose monitoring.
How GLP-1 Works in the Body
The science behind GLP-1 is deeply intertwined with gut health and endocrine function. When you take a GLP-1 agonist, you are essentially giving your body an artificial boost of this vital gut hormone.
1. Glucose-Dependent Insulin Secretion: The drug doesn't just force insulin into the system. It intelligently tells the pancreas to release extra insulin only when blood sugar levels are high, preventing the common problem of hypoglycemia (low blood sugar).
2. Gastric Emptying and Satiety: One of the most celebrated features is its effect on the digestive tract. By slowing down the rate at which the stomach empties its contents, GLP-1 agonists naturally make you feel fuller for longer. This powerful sensation of satiety directly translates into reduced calorie intake and successful weight management—a major goal for anyone considering a GLP-1 3 month supply.
3. Cardiovascular Benefits: Beyond just sugar and weight, many GLP-1 drugs have been shown to have positive effects on cardiovascular health, making them a cornerstone therapy for individuals at high risk of heart disease. This systemic benefit elevates the treatment from mere blood sugar control to holistic cardiovascular support.
